Impact of chimeric immune receptor extracellular protein domains on T cell function

Gene Therapy

Volumn 6, Issue 3, 1999, Pages 412-419

  Patel, S D ^a   Moskalenko, M ^a   Smith, D ^a,b   Maske, B ^a   Finer, M H ^a   McArthur, J G ^a  

^a CELL GENESYS INC   (United States)

^b MONOGRAM BIOSCIENCES   (United States)

Author keywords

Chimeric receptor; CTL; HIV; Protein engineering

Indexed keywords

ANTIBODY; ANTIGEN; CHIMERIC PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN; LIGAND; MEMBRANE PROTEIN; RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING AFFINITY; CANCER; CELL FUNCTION; EXTRACELLULAR SPACE; IMMUNOTHERAPY; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CLONING, MOLECULAR; CYTOKINES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNOTHERAPY, ADOPTIVE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0033002083     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300831     Document Type: Article

References (15)

1. Eshhar Z, Waks T, Gross G, Schindler D. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci USA 1993; 90: 720-724.
2. McGuinness R et al. Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor. Hum Gene Ther (in press).
3. Moritz D, Wels W, Mattern J, Groner B. Cytotoxic T lymphocytes with a grafted recognition specifity for ERBB2-expressing tumor cells. Proc Natl Acad Sci USA 1994; 91: 4428-4432.
4. + T lymphocytes armed with universal T-cell receptors. Blood 1994; 84: 2878-2889.
5. Stancoviski I et al. Targetting of T lymphocytes to Neu/Her-2-expressing cells using chimeric receptor single chain Fv receptors. J Immunol 1993; 151: 6577-6582.
6. Hwu P et al. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res 1995; 55: 3369-3373.
7. Hwu P et al. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med 1993; 178: 361-366.
8. Fitzer-Attas C, Schindler D, Waks T, Eshhar Z. Direct T cell activation by chimeric single chain Fv-Syk promotes Syk-Cbl association and Cbl phosphorylation. J Biol Chem 1997; 272: 8551-8557.
9. Lustgarten J, Eshhar Z. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes. Eur J Immunol 1995; 25: 2985-2991.
10. Moritz D, Groner B. A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity. Gene Therapy 1995; 8: 539-546.
11. Gorny M, Gianakakos V, Sharpe S, Zolla-Pazner S. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc Natl Acad Sci USA 1989; 86: 1624-1628.
12. Xu J et al. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J Virol 1991; 65: 4832-4838.
13. Finer M et al. Kat: a high efficiency retroviral transduction system for primary human lymphocytes. Blood 1994; 83: 43-50.
14. Olshevsky U et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol 1990; 64: 5701-5707.
15. Bedzyk W et al. Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody. J Biol Chem 1990; 265: 18615-18620.